Regulatory

The company announced a prestigious botanical reference-materials partnership with the American Herbal Pharmacopoeia.

Industry trade associations CRN and NPA slammed FDA for abdicating its authority and failing to publicize its stance on an ingredient.

“What’s going to come next? Well, what I think is going to come next is more specific orders,” said attorney John Villafranco of Kelley Drye & Warren LLP.

Bayer’s FTC legal battle triumph underscores the rightful difference between dietary supplements and drugs.

Responses from supplement industry leaders aimed to put the findings in context.

The company developed its Reb M in partnership with The Coca-Cola Co., who will co-own the patent.

The association is now in the process of drafting quality standards for algae biomass that will eventually feed into a verification program and seal the association plans to roll out in Q1 2016.

The monograph is now part of The U.S. Pharmacopeia’s (USP) Dietary Supplements Compendium.

The agency is now reviewing the petition and a final decision could come in early 2016.

Is the U.S. DSHEA model, which does not include premarket registration, as effective-or even more so-for supplement consumers?

The dietary supplement industry's GMP compliance is a work in progress. How the industry is living with-and learning from-FDA Form 483s

The U.S. supplements industry has lost some credibility with media and consumers. Could a proposal based on the pharmaceutical industry that is not premarket approval help to alleviate concerns?

What can industry take away from this year’s New York Attorney General probe?

In Canada, products containing BLIS K12 can now claim to “promote oral health."

Lesaffre has licensed ibSium exclusively in Canada to a company called Medical Futures Inc., which plans to launch an IBS product in the near future.

Ray Matulka, PhD, director of toxicology for the Burdock Group, will discuss the regulatory boundaries for probiotics as supplements and foods in the United States.

Former Peanut Corp. owner will go to prison for 28 years following a salmonella outbreak that killed nine people.

Certain businesses will be expected to comply with the new rules by September 2016.

Deciding whether or not to go non-GMO? Here are five points to consider.

After what appeared like a quiet couple of months, NY AG Eric Schneiderman’s dietary supplements investigation has resurfaced.

Hundreds of animal food ingredients listed in AAFCO's Official Publication are facing new scrutiny from FDA.

An ingredient supplier’s view of non-GMO certification

Do non-GMO labels benefit from consumers’ inability to distinguish between organic and non-GMO?

Would overlap between USDA Organic and the Safe and Accurate Food Labeling Act confuse consumers?

The group will focus on establishing non-GMO standards for the supplements industry.

The U.S. House passed the Safe and Accurate Food Labeling Act in July. What’s the current status of GMO-labeling laws, and is federal GMO labeling now imminent?

If an FDA investigational new drug (IND) application for hemp CBD is accepted, some industry experts fear the door could close on CBD ever reaching legal acceptance as a food or dietary supplement ingredient.